(Albany, US) DelveInsight launched a new report on Cold Agglutinin Disease (CAD) – Market Insights, Epidemiology, and Market Forecast-2030
DelveInsight’s “Cold Agglutinin Disease (CAD) – Market Insights, Epidemiology, and Market Forecast-2030“ report delivers an in-depth understanding of the Cold Agglutinin Disease (CAD), historical and forecasted epidemiology as well as the Cold Agglutinin Disease (CAD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the report:
1. Cold Agglutinin Disease frequency is usually more in females than in males. The male to female ratio is around 45:55.
2. The United States has the highest percentage of Cold Agglutinin Disease prevalent diagnosed & treated patients.
3. The prevalence of Cold Agglutinin Disease in Europe is assumed to be about 10 cases per million.
Key benefits of the report:
1. Cold Agglutinin Disease market report covers a descriptive overview and comprehensive insight of the Cold Agglutinin Disease epidemiology and Cold Agglutinin Disease market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Cold Agglutinin Disease market report provides insights on the current and emerging therapies.
3. Cold Agglutinin Disease market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. Cold Agglutinin Disease market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Cold Agglutinin Disease market.
Request for sample pages: https://www.delveinsight.com/sample-request/cold-agglutinin-disease-cad-market
The key players in Cold Agglutinin Disease market are:
2. Apellis Pharmaceuticals
3. Janssen Pharmaceutical
The launch of the emerging therapies is expected to significantly impact the Cold Agglutinin Disease treatment scenario in the upcoming years:-
Table of contents
1. Key Insights
2. Cold Agglutinin Disease Market Overview at a Glance
3. Executive summary
5. Cold Agglutinin Disease Epidemiology and Market Methodology
6. Cold Agglutinin Disease Background and Overview
7. Cold Agglutinin Disease Epidemiology and Patient Population
8. Cold Agglutinin Disease Total Prevalent cases in 7MM
9. Country Wise-Epidemiology of Cold Agglutinin Disease
9.1.1. United States
9.1.2. EU5 Countries
9.1.7. The United Kingdom
10. Cold Agglutinin Disease Treatment Algorithm, Current Treatment, and Medical Practices
11. Unmet Needs
12. Cold Agglutinin Disease Emerging Therapies
12.1.1. Key Cross Competition
12.1.2. Sutimlimab: Sanofi
12.1.3. APL-2: Apellis Pharmaceuticals
12.1.4. Bortezomib: Janssen Pharmaceutical
13. Cold Agglutinin Disease 7 Major Market Analysis
13.1.1. Key Findings
14. Seven Major Market Outlook
14.1.1. United States Market Size
14.1.6. United Kingdom
15. Market Drivers
16. Market Barriers
18. Case Studies
19. KOL Views
21. DelveInsight Capabilities
23. About DelveInsight
Download a free sample report: https://www.delveinsight.com/sample-request/cold-agglutinin-disease-cad-market
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States